跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARANESP darbepoetin alfa (rch) 20 microgram/0.5mL injection syringe - TGA Drug Approval Details
Approvals
/
TGA
/
ARANESP darbepoetin alfa (rch) 20 microgram/0.5mL injection syringe
Approved
STANDARD
ARANESP darbepoetin alfa (rch) 20 microgram/0.5mL injection syringe
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
158add23415b5f13
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
158add23415b5f13
Product Name
ARANESP darbepoetin alfa (rch) 20 microgram/0.5mL injection syringe
Artg Id
77952
Artg Name
ARANESP darbepoetin alfa (rch) 20 microgram/0.5mL injection syringe
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2001-07-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-04194-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
158add23415b5f13
Type
Standard
Back to TGA Approvals